- doi:10.1016/s0149-7634(96)00037-1. PMID 9195603.
Danysz W,
Dekundy A,
Scheschonka A,
Riederer P (February 2021). "Amantadine:
reappraisal of the timeless...
- Drug
Administration (FDA).
Retrieved 28 July 2019.
Danysz W,
Dekundy A,
Scheschonka A,
Riederer P (February 2021). "Amantadine:
reappraisal of the timeless...
- 35 (5): 235–238. doi:10.1023/A:1011905302667.
Danysz W,
Dekundy A,
Scheschonka A,
Riederer P (February 2021). "Amantadine:
reappraisal of the timeless...
- e2300595. doi:10.1002/ardp.202300595. PMID 38128028.
Danysz W,
Dekundy A,
Scheschonka A,
Riederer P (February 2021). "Amantadine:
reappraisal of the timeless...
- 47–55. doi:10.1055/s-2007-979191. PMID 10333162.
Danysz W,
Dekundy A,
Scheschonka A,
Riederer P (February 2021). "Amantadine:
reappraisal of the timeless...
- 1146/annurev-pharmtox-022423-014645. PMID 37585659.
Danysz W,
Dekundy A,
Scheschonka A,
Riederer P (February 2021). "Amantadine:
reappraisal of the timeless...
- 5433 - 5444
Zhongshu Tang,
Oussama El Far,
Heinrich Betz, and
Astrid Scheschonka. Pias1
Interaction and
Sumoylation of
Metabotropic Glutamate Receptor...
- 1016/S0014-5793(02)02361-X. PMID 11943148. S2CID 44474808. Tang Z, El Far O, Betz H,
Scheschonka A (November 2005). "Pias1
interaction and
sumoylation of metabotropic...
- KM, ****van BM,
Brown D,
Fischer ER,
Watson N,
Blumer KJ,
Gerfen CR,
Scheschonka A,
Kehrl JH (July 1998). "Expression of GTPase-deficient Gialpha2 results...
- KM, ****van BM,
Brown D,
Fischer ER,
Watson N,
Blumer KJ,
Gerfen CR,
Scheschonka A,
Kehrl JH (1998). "Expression of GTPase-deficient Gialpha2 results...
